Related Experiment Video
Updated: Aug 30, 2026
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations
R Scott Williams1, Daniel I Chasman, D Duong Hau
1Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.
Abstract:
Most cancer-associated BRCA1 mutations identified to date result in the premature translational termination of the protein, highlighting a crucial role for the C-terminal, BRCT repeat region in mediating BRCA1 tumor suppressor function. However, the molecular and genetic effects of missense mutations that map to the BRCT region remain largely unknown. Using a protease-based assay, we directly assessed the sensitivity of the folding of the BRCT domain to an extensive set of truncation and single amino acid substitutions derived from breast cancer screening programs. The protein can tolerate truncations of up to 8 amino acids, but further deletion results in drastic BRCT folding defects. This molecular phenotype can be correlated with an increased susceptibility to disease. A cross-validated computational assessment of the BRCT mutation data base suggests that as much as half of all BRCT missense mutations contribute to BRCA1 loss of function and disease through protein-destabilizing effects. The coupled use of proteolytic methods and computational predictive methods to detect mutant BRCA1 conformations at the protein level will augment the efficacy of current BRCA1 screening protocols, especially in the absence of clinical data that can be used to discriminate deleterious BRCT missense mutations from benign polymorphisms.
Insights
BRCA1 BRCT missense mutations can destabilize the protein, increasing cancer risk. This study reveals that protease assays and computational methods can identify these harmful mutations, improving cancer screening.
Area of Science:
- Genetics and Molecular Biology
- Cancer Research
- Protein Biochemistry
Background:
- Most known cancer-associated BRCA1 mutations lead to premature protein termination.
- The C-terminal BRCT repeat region is critical for BRCA1 tumor suppressor activity.
- The impact of missense mutations within the BRCT region is largely uncharacterized.
Purpose of the Study:
- To investigate the molecular and genetic effects of missense mutations in the BRCA1 BRCT domain.
- To assess the folding stability of the BRCT domain in response to various mutations.
- To correlate folding defects with disease susceptibility.
Main Methods:
- Utilized a protease-based assay to evaluate BRCT domain folding sensitivity.
- Introduced extensive truncation and single amino acid substitutions.
- Employed cross-validated computational methods to assess mutation databases.
Main Results:
- BRCT domain tolerates truncations up to 8 amino acids; further deletions cause significant folding defects.
- A correlation exists between molecular folding phenotypes and increased disease susceptibility.
- Computational analysis suggests approximately 50% of BRCT missense mutations impair BRCA1 function by destabilizing the protein.
Conclusions:
- Proteolytic and computational methods can detect destabilizing BRCA1 mutations at the protein level.
- These combined approaches can enhance BRCA1 screening efficacy, particularly when clinical data is limited.
- Identifying deleterious BRCT missense mutations is crucial for accurate cancer risk assessment.
More Related Videos
Related Concept Videos
01:49Protein Folding
01:37The Unfolded Protein Response
02:27Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...